Alberta Most cancers Basis publicizes new Breakthrough Fund recipient, driving business success of most cancers analysis breakthroughs

Article content material

Native startup Oncobiotix to obtain $100,000 to advance most cancers and microbiome analysis

CALGARY, Alberta, Could 31, 2024 (GLOBE NEWSWIRE) — The Alberta Most cancers Basis is happy to announce the most recent recipient of the novel Breakthrough Fund—Calgary start-up Oncobiotix might be awarded $100,000 to additional advance its venture centered on most cancers and microbiome analysis. The Breakthrough Fund is a transformative method to philanthropy, designed to propel Alberta’s most promising most cancers analysis from the lab to the market, resulting in improved affected person outcomes.

Article content material

This venture, led by Dr. Saif Sikdar, CEO of Oncobiotix and postdoctoral analysis fellow on the Riddell Centre for Most cancers Immunotherapy, goals to harness microbiome-derived compounds to reinforce most cancers immunotherapy. Immunotherapies, notably immune checkpoint blockade (ICB) therapies, supply new hope for sufferers with sure cancers. Nonetheless, the efficacy of ICB remedy is proscribed, with solely 20-30 per cent of sufferers responding to therapy. One issue contributing to that is the composition of micro organism within the affected person’s intestine, known as their microbiome, which is commonly very totally different from affected person to affected person. A microbiome is a ‘group’ of tiny organisms—micro organism, viruses, fungi—that reside in and on a physique, notably within the intestine. Microbiomes play an important function in digestion, immunity and temper regulation, performing like a mini ecosystem that helps your total well being.

Oncobiotix is trying to overcome these limitations by figuring out the chemical mediators of ICB enhancement which might be secreted by the “good” micro organism and develop them into adjuvant drug therapies for immunotherapy. These medication could be extra reasonably priced than bacterial transplantation, simpler to fabricate, delivered in hospitals and unaffected by antibiotic therapy.

Article content material

Article content material

“Our drug holds the promise to enhance the lives of most cancers sufferers by harnessing the ability of their microbiome to reinforce their response to immunotherapy,” says Saif Sikdar. “The Breakthrough Fund will considerably assist us optimize our drug dosing routine earlier than initiating the IND-enabling research and subsequent medical trials. This can be a essential step in direction of bringing a promising remedy to sufferers. We deeply recognize the help from the Alberta Most cancers Basis and Breakthrough Fund buyers.”

“Congratulations to Dr. Sikdar and his crew on this well-deserved recognition,” says Wendy Beauchesne, CEO, Alberta Most cancers Basis. “The Breakthrough Fund was created to bridge the hole between analysis and sensible software, making certain that huge concepts like theirs attain the market, turning into accessible and helpful to sufferers with most cancers. This venture aligns with the Basis’s mission to reinforce the standard of life for Albertans going through most cancers by supporting developments in early detection and therapy.”

Alberta is house to among the world’s brightest scientific minds engaged on progressive most cancers therapies for higher affected person outcomes. The Breakthrough Fund helps these innovators by offering the monetary backing wanted to maneuver concepts from analysis labs to world markets. By harnessing the enterprise instincts of Alberta’s personal sector and donors, the Fund goals to speed up the commercialization of those tasks, which can embody new therapeutics, diagnostics or medical units, all of which give attention to enhancing how most cancers is handled.

Article content material

“The Breakthrough Fund combines the strengths of philanthropy and funding to propel promising analysis in direction of commercialization,” says Cory Janssen, chair, Breakthrough Fund and co-founder and co-CEO, AltaML. “This mannequin not solely helps the event of recent most cancers therapies but in addition attracts funding to our province, driving financial progress and enhancing our world competitiveness in well being innovation.”

The Breakthrough Fund’s mannequin invitations native buyers to make a five-year dedication, supporting proof of precept grants yearly, serving to advance analysis to a stage the place enterprise capitalists and companions can deliver the options to market. Profitable commercialization will result in returns reinvested into the fund, making a sustainable cycle of innovation and help.

That is the inaugural 12 months of the Alberta Most cancers Basis Breakthrough Fund, with the primary two recipients named in Edmonton earlier this 12 months.

For media inquiries, contact: Ryan Kelly | VP, Communications and Group Partnerships
Alberta Most cancers Basis | 780.220.8791 | ryan.kelly@albertacancer.ca

Article content material

Concerning the Alberta Most cancers Basis
Creating extra moments for Albertans going through most cancers by inspiring our group to offer to innovation in detection, therapy and care. Albertans serving to Albertans is on the core of all the pieces the Alberta Most cancers Basis does. Because the official fundraising accomplice for each most cancers centre in Alberta, our very function comes from our want to create extra moments for all Albertans going through most cancers, irrespective of the place they reside or the kind of most cancers they’re going through. From the Canmore mountains to the canola fields in Lloydminster, we make life higher for Albertans going through most cancers by supporting world-class analysis and affected person care, near house. For extra data, go to albertacancer.ca.

Article content material